What is the ideal frequency of follow-up of LDL-C, HDL-C and serum TGs in patients with CKD?
The ideal frequency of follow-up of LDL-C, HDL-C and serum TGs in patients with CKD is unknown. Since any benefits of lipid-lowering treatment are likely to accrue over years rather than months or weeks, the Work Group suggests that cardiovascular risk be assessed annually in most patients with CKD. However, more frequent (or less frequent) follow-up measurements may be appropriate based on the clinical status of the patient.